# CAN SLIM Progress Board

Last updated: 2026-09-14

Frozen quantitative v1 remains research-complete but not production-ready. FWD1 and EXH2 continue unchanged. The theory-fidelity path through #36 now has frozen #32/#33/#34/#35 contracts and a frozen #36 execution baseline.

## Repository boundary for #33

**Canonical #33 implementation and P8 morphology validation live in `azharmz/ussy-oneil-patterns`.**

This repository is the CAN SLIM parent/HQ. No new #33 detector/evaluator development should be added here.

Frozen production contract: `oneil-pattern-output-v2`

Production core only:

- `FLAT_BASE`
- `DOUBLE_BOTTOM`
- `CUP_WITHOUT_HANDLE`
- `CUP_WITH_HANDLE`

P6 advanced patterns (`ASCENDING_BASE`, `BASE_ON_BASE`) remain:

`DEFERRED / NOT PRODUCTION-VALIDATED / FROZEN UNTIL NEW AUTHORITATIVE MORPHOLOGY EVIDENCE EXISTS`

They must not enter #34/#35/#36 production-contract consumption.

## Canonical v1 state

| Area | Status |
|---|---|
| Independent CAN SLIM project | COMPLETE |
| Frozen Musaffa universe | COMPLETE / FROZEN |
| Production OHLCV / data infrastructure | COMPLETE |
| SEC/PIT fundamentals | COMPLETE / FROZEN |
| C / A | COMPLETE |
| N / S / L proxies | COMPLETE |
| I institutional sponsorship | COMPLETE / NOT PROMOTED as hard filter |
| M / SPY+QQQ ablation | COMPLETE / NOT PROMOTED |
| Historical candidates v1 | COMPLETE |
| X1-X4 / X3 | COMPLETE / PARKED |
| PORT1 / costs / robustness | COMPLETE |
| CAN SLIM quantitative v1 | RESEARCH COMPLETE |
| FWD1 | LIVE / ACCUMULATING |
| EXH2 | LIVE / PROSPECTIVE |
| Production integration | BLOCKED — FWD1 gate not met |

Historical v1 results remain frozen evidence and must not tune the theory-faithful path.

## Theory Fidelity / v2 path

| # | Workstream | Status |
|---:|---|---|
| 25 | Theory Fidelity Audit — O'Neil vs engine v1 | **COMPLETE** |
| 26 | Proper-base definitions | **COMPLETE** |
| 27 | Pivot / buy-point definition | **COMPLETE** |
| 28 | Breakout + volume confirmation | **COMPLETE** |
| 29 | RS / leadership fidelity | **COMPLETE** |
| 30 | C/A/S/I/M role fidelity | **COMPLETE** |
| 31 | Sell / risk-management fidelity | **COMPLETE** |
| 32 | Theory-faithful candidate specification | **COMPLETE / FROZEN v1** |
| 33 | O'Neil Pattern Recognition Engine | **CORE COMPLETE / FROZEN — P8 CONDITIONAL PASS** |
| 34 | Theory-faithful candidate generator | **COMPLETE / FROZEN v1** |
| 35 | New-candidate validation | **COMPLETE / FROZEN — CONDITIONAL PASS** |
| 36 | Execution / entry research | **BASELINE FROZEN / DIAGNOSTIC COMPLETE / PRIMARY PERFORMANCE VALIDATION BLOCKED_ON_ELIGIBLE_POPULATION** |

## Frozen #32/#34 staged contract

```text
BASE_RECOGNIZED
→ PIVOT_DEFINED
→ PIVOT_CROSSED
→ BREAKOUT_CONFIRMED
→ CANSLIM_ELIGIBLE
```

Missing/stale evidence remains explicit `NOT_EVALUABLE/NOT_IMPLEMENTED`.

## #34 — Theory-Faithful Candidate Generator — FROZEN

Canonical freeze record:

`docs/decisions/2026-09-13-34-theory-faithful-candidate-generator-freeze.md`

Key frozen behavior includes strict four-core #33 consumption, first-cross chronology after `structural_end`, breakout-day volume confirmation using prior 50 completed sessions with `>=1.40x`, PIT C/A adapters, L RS percentile, M entry state, and S/I contextual evidence. P6 remains disabled.

Final verification run `34758050282` → **SUCCESS**, 9 tests passed.

## #35 — New-Candidate Validation — COMPLETE / FROZEN

Terminal verdict:

`CONDITIONAL PASS / VALIDATION COMPLETE WITH UPSTREAM #33 MORPHOLOGY DEBT PRESERVED`

Canonical historical run `34763920536`:

- 265,642 observations;
- V35-A/B/C findings = 0;
- frozen 60-case corpus = 20 RECOGNIZED / 20 AMBIGUOUS / 20 REJECTED.

V35-D:

- candidate identity 60/60 reproducible;
- pattern/status mismatch = 0;
- no future bars;
- first-cross chronology 60/60 MATCH;
- volume ratio 60/60 MATCH;
- final stage 60/60 MATCH.

Independent source-evidence audit run `34765922653` → **SUCCESS**:

- C 60/60 MATCH;
- A 60/60 MATCH;
- L 60/60 MATCH;
- M 60/60 MATCH;
- 1,300-security historical RS cross-section;
- PIT violations = 0;
- future-performance fields used = false.

Canonical decision:

`docs/decisions/2026-09-14-35-terminal-validation-decision.md`

Upstream #33 morphology debt remains preserved for potentially long CWH handles and relatively large DB second-trough undercuts. No threshold may be derived from #35 validation data.

## #36 — Execution / Entry

### Canonical baseline — FROZEN v1

Specification:

`docs/methodology/36-execution-entry-spec-v1.md`

Contract:

`36-execution-entry-v1`

```text
CANSLIM_ELIGIBLE at T
→ signal known after close T
→ earliest causal execution T+1
→ fill at observed T+1 open iff pivot <= open <= pivot * 1.05
```

No same-day hindsight fill, synthetic limit fill, arbitrary delayed fill, or performance-selected entry timing is part of the canonical baseline.

Semantic validation:

- initial run `34784341195` failed only from CI import path before assertions;
- tooling-only fix: `PYTHONPATH=src`;
- canonical run `34785545504` → **SUCCESS**, 11 passed;
- no semantic threshold or upstream contract changed.

Freeze decision:

`docs/decisions/2026-09-14-36-execution-entry-v1-freeze.md`

### R0/R1/R2/R3 research variants

Preregistration:

`docs/methodology/36-entry-variants-prereg-v1.md`

Variant integrity run `34785658367` → **SUCCESS**.

- R0 = frozen T+1-open baseline;
- R1 = first valid observed open T+1–T+3;
- R2 = full daily pivot hold T+1/T+2, then next valid open;
- R3 = +2% near-pivot retest/reclaim research proxy; explicitly non-authoritative.

### Primary actionable population gate

Source-population audit run `34786499862` → **SUCCESS** against the frozen canonical #35 artifact.

Stage counts across 265,642 observations:

- `NOT_ELIGIBLE`: 241,514
- `PIVOT_DEFINED`: 23,656
- `PIVOT_CROSSED`: 334
- `BREAKOUT_CONFIRMED`: 138
- `CANSLIM_ELIGIBLE`: **0**

Therefore the preregistered actionable R0/R1/R2/R3 performance comparison is:

`BLOCKED_ON_ELIGIBLE_POPULATION`

No performance metric was inspected before that gate was recorded.

Decision:

`docs/decisions/2026-09-14-36-entry-primary-population-gate.md`

### Separate BREAKOUT_CONFIRMED execution diagnostic

Preregistered separately after the zero-population gate and before outcome inspection:

`docs/methodology/36-breakout-confirmed-execution-diagnostic-v1.md`

Run `34786603831` → **SUCCESS**.

Integrity findings: **0**.

Population:

- 138 frozen `BREAKOUT_CONFIRMED` candidate records;
- 6 securities;
- only 12 unique security-date signal events.

Execution coverage:

- R0: 18/138 = 13.0%;
- R1: 21/138 = 15.2%, +3 incremental candidate fills vs R0;
- R2: 13/138 = 9.4%, +2 incremental vs R0;
- R3: 18/138 = 13.0%, +2 incremental vs R0.

Fixed 5/10/20/30-session returns plus 20-session MFE/MAE were computed only after integrity passed. Because the 138 candidate records collapse to only 12 security-date events, candidate-level outcomes are strongly clustered and must not be treated as 138 independent trials.

No R1/R2/R3 promotion is authorized. R3 remains a non-authoritative research proxy. This diagnostic is **not CANSLIM-eligible strategy performance**.

Terminal decision:

`docs/decisions/2026-09-14-36-entry-diagnostic-terminal.md`

Terminal #36 state:

`BASELINE FROZEN / DIAGNOSTIC COMPLETE / PRIMARY PERFORMANCE VALIDATION BLOCKED_ON_ELIGIBLE_POPULATION`

## Data boundary

Production daily scanning may continue using the compact R2 ready snapshot (~300 bars/security). Historical validation/research may use the purpose-built full-history archive. #36 may consume next-session bars only after a frozen signal T; future bars must never alter signal-T eligibility.

## Forward tracks remain frozen

FWD1 boundary remains exclusive 2026-09-09 with formal review only after both >=12 completed calendar months and >=50 closed X3 portfolio trades. EXH2 remains separate and prospective. Theory-fidelity/#34/#35/#36 findings must not be retrofitted into either track.

## Active work from here

1. Keep #33/#34/#35 and the frozen #36 R0 baseline unchanged.
2. Do not promote R1/R2/R3 from the clustered breakout-confirmed diagnostic.
3. Wait for a genuine frozen `CANSLIM_ELIGIBLE` historical/forward source population before primary #36 performance validation.
4. Preserve #33 morphology debt and keep P6 advanced patterns out of production.
5. Any new downstream workstream after #36 must receive its own explicit scope/specification rather than modifying the frozen candidate/entry contracts.
